Prognostic factors derived from a prospective database dictate clinical biology of anal cancer-Reference-Cited by-同舟云学术

Prognostic factors derived from a prospective database dictate clinical biology of anal cancer

Published:2010-06-08 Issue:17 Volume:116 Page:4007-4013
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ajani Jaffer A.,Winter Kathryn A.,Gunderson Leonard L.,Pedersen John,Benson Al B.,Thomas Charles R.,Mayer Robert J.,Haddock Michael G.,Rich Tyvin A.,Willett Christopher G.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal;Nigro;Cancer,1983

3. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial;Ajani;JAMA,2008

4. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy5-fluorouracil and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research;Lancet,1996

5. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups;Bartelink;J Clin Oncol,1997

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-treatment magnetic resonance imaging in anal cancer: large-scale evaluation of mrT, mrN and novel staging parameters;British Journal of Cancer;2024-08-21

2. A population-based analysis of the impact of 1 vs. 2 doses of mitomycin on patterns of failure of anal cancer patients treated with concurrent chemoradiotherapy;Radiotherapy and Oncology;2024-07

3. Efficacy and Toxicity of (Chemo)Radiation Therapy in HIV+ Patients with Squamous Cell Anal Cancer, a Subgroup Analysis of the National Multicenter Cohort FFCD-ANABASE;International Journal of Radiation Oncology*Biology*Physics;2024-06

4. Clinical outcomes and prognostic factors of concurrent chemoradiotherapy for anal squamous cell carcinoma in Japan;International Journal of Clinical Oncology;2024-05-31

5. Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma;npj Precision Oncology;2024-04-23